The Korean Journal of Pain

Review Article

01 October 2023

Repetitive transcranial magnetic stimulation in central post-stroke pain: current status and future perspective

Riva Satya Radiansyah and Deby Wahyuning Hadi

Korean J Pain 2023; 36: 408-424

Central post-stroke pain (CPSP) is an incapacitating disorder that impacts a substantial proportion of stroke survivors and can diminish their quality of life. Conventional therapies for CPSP, including tricyclic antidepressants, anticonvulsants, and...

Key Words: Analgesics, Opioid; Central Post-Stroke Pain; Cerebral Cortex; Neuralgia; Pain; Pain, Intractable; Quality of Life; Stroke; Therapeutics; Transcranial Magnetic Stimulation.

Review Article

01 July 2023

Coccydynia: anatomic origin and considerations regarding the effectiveness of injections for pain management

Shin-Hyo Lee, Miyoung Yang, Hyung-Sun Won et al.

Korean J Pain 2023; 36: 272-280

Coccydynia is a debilitating pain disorder. However, its pathophysiology is not well understood. When approaching coccydynia, the exact underlying cause of pain must be identified to develop an appropriate treatment plan. The specific approach to coc...

Key Words: Anatomy; Chronic Pain; Coccyx; Ganglia, Sympathetic; Injections; Low Back Pain; Lumbosacral Region; Nerve Block; Pelvic Pain; Prevalence; Sacrococcygeal Region.

Review Article

01 July 2023

Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms

Eric J. Wang, Jay Karri, Nuj Tontisirin et al.

Korean J Pain 2023; 36: 281-298

There is increasing evidence that the relationship between chronic pain and infections is complex and intertwined. Bacterial and viral infections can cause pain through numerous mechanisms such as direct tissue damage and inflammation, the induction ...

Key Words: Analgesia; Anti-Bacterial Agents; Anti-Infective Agents; Antiviral Agents; Central Nervous System Sensitization; Chronic Pain; Infections; Neuralgia; Nociceptive Pain; Pain Management.

Review Article

01 July 2023

Antimicrobial therapies for chronic pain (part 2): the prevention and treatment of chronic pain

Eric J. Wang, Edward Dolomisiewicz, Jay Karri et al.

Korean J Pain 2023; 36: 299-315

The discovery and development of antimicrobial therapies represents one of the most significant advancements in modern medicine. Although the primary therapeutic intent of antimicrobials is to eliminate their target pathogens, several antimicrobials ...

Key Words: Analgesia; Anti-Bacterial Agents; Anti-Infective Agents; Antiviral Agents; Central Nervous System Sensitization; Chronic Pain; Infections; Neuralgia; Nociceptive Pain; Pain Management.

Review Article

01 April 2023

Practical strategies for the prevention and management of chronic postsurgical pain

Bo Rim Kim, Soo-Hyuk Yoon, and Ho-Jin Lee

Korean J Pain 2023; 36: 149-162

Chronic postsurgical pain (CPSP) is a multifactorial condition that affects a significant proportion of patients undergoing surgery. The prevention and management of CPSP require the identification of preoperative risk factors to screen high-risk pat...

Key Words: Acute pain; Chronic Pain; Neuralgia; Pain Management; Pain, Postoperative; Perioperative Medicine; Postoperative Complications; Surgical Procedures, Operative.

Review Article

01 January 2023

Current scenario and future applicability of antivirals against herpes zoster

Sang Hun Kim

Korean J Pain 2023; 36: 4-10

Herpes zoster (HZ) is a common disease in the aging population and immunocompromised individuals, with a lifetime risk of 20%–30% that increases with age. HZ is caused by reactivation of the varicella-zoster virus (VZV), which remains latent in...

Key Words: Acyclovir; Amenamevir; Antiviral Agents; ASP2151; Brivudine; Famciclovir; Herpes Zoster; Herpesvirus 3, Human; Neuralgia, Postherpetic; Valacyclovir; Varicella Zoster Virus Infection.

Review Article

01 January 2023

No more tears from surgical site infections in interventional pain management

Seungjin Lim, Yeong-Min Yoo, and Kyung-Hoon Kim

Korean J Pain 2023; 36: 11-50

As the field of interventional pain management (IPM) grows, the risk of surgical site infections (SSIs) is increasing. SSI is defined as an infection of the incision or organ/space that occurs within one month after operation or three months after im...

Key Words: Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Culture; Cefazolin; C-Reactive Protein; Discitis; Drug Combinations; Drug Resistance, Bacterial; Guideline; Serum Amyloid A Protein; Surgical Wound Infection; Vancomycin.